HYPERTROPHIC CARDIOMYOPATHY (HCM)
Clinical trials for HYPERTROPHIC CARDIOMYOPATHY (HCM) explained in plain language.
Never miss a new study
Get alerted when new HYPERTROPHIC CARDIOMYOPATHY (HCM) trials appear
Sign up with your email to follow new studies for HYPERTROPHIC CARDIOMYOPATHY (HCM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart drug mavacamten shows promise in Real-World study
Disease control CompletedThis study looked at 222 adults with obstructive hypertrophic cardiomyopathy, a condition where the heart muscle thickens and blocks blood flow. Researchers compared those who took mavacamten (Camzyos) with those on standard therapy, measuring changes in heart function and sympto…
Matched conditions: HYPERTROPHIC CARDIOMYOPATHY (HCM)
Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New heart pill aims to ease thick heart muscle symptoms
Disease control CompletedThis study tested a new daily pill called CK-3773274 (aficamten) in 96 adults with symptomatic hypertrophic cardiomyopathy, a condition where the heart muscle is abnormally thick. The goal was to find the right dose and check safety, including effects on heart pumping strength. P…
Matched conditions: HYPERTROPHIC CARDIOMYOPATHY (HCM)
Phase: PHASE2 • Sponsor: Cytokinetics • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC